We analyzed the kinetics and pharmacology of EPSCs in two kinds of neurons in the embryonic avian ciliary ganglion. Wholecell voltage-clamp recordings revealed that the singly innervated ciliary neurons had large-amplitude (1.5-8.0 nA) EPSCs that could be classified according to the kinetics of their falling phases. Most of the neurons responded with an EPSC the falling phase of which followed a double exponential time course with time constants of ϳ1 and 10 msec. The EPSCs of the remaining ciliary neurons followed a single time constant (ϳ8 msec). Multiple innervated choroid neurons had smalleramplitude responses (0.2-1.5 nA when all inputs were activated) that appeared to contain only a slowly decaying component ( ϭ 12 msec). The fast and slow components of EPSC decay seen in most ciliary neurons could be pharmacologically isolated with two toxins against nicotinic acetylcholine receptors (AChRs). The fast component was blocked by 50 nM ␣-bungarotoxin (␣-BuTx), which binds ␣7-subunit-containing AChRs. The slow component was selectively blocked by 50 nM ␣-conotoxin MII (␣-CTx-MII), which blocks mammalian AChRs containing an ␣3/␤2 subunit interface. A combination of both ␣-BuTx and ␣-CTx-MII abolished nearly all evoked current. Similar pharmacological results were found for ciliary neurons with monoexponentially decaying EPSCs and for choroid neurons. These results suggest that nerve-evoked transmitter acts on at least two different populations of AChRs on autonomic motor neurons in the ciliary ganglion.
Nicotinic acetylcholine receptors (AChRs) are a family of ligandgated oligomeric ion channels assembled from a pool of 15 or more unique subunits. The application of recombinant DNA technology has revealed a rich spectrum of AChR subunit genes expressed by neurons (for review, see Sargent, 1993; Decker et al., 1995; McGehee and Role, 1995; Lindstrom, 1996; Role and Berg, 1996; Albuquerque et al., 1997) . Rapid excitatory synaptic transmission in autonomic neurons is mediated by AChRs, and autonomic neurons must therefore make at least one class of receptors that underlie that function. Many autonomic neurons, however, express mRNAs and gene products corresponding to several AChR subunits and may be capable of assembling them into several different oligomeric AChRs (Listerud et al., 1991; Corriveau and Berg, 1993; Mandelzys et al., 1995) . This raises the question of whether these AChRs serve novel roles in addition to their classic role.
We have studied AChR f unction in parasympathetic motor neurons of the embryonic chicken ciliary ganglion, in which AChR expression is diverse and AChRs may serve novel roles. At least five different AChR subunit genes-␣3, ␣5, ␣7, ␤2, and ␤4 -are expressed in the ciliary ganglion, and it is likely that each neuron expresses the f ull complement of subunits that is found in the ganglion as a whole (Boyd et al., 1988; Corriveau and Berg, 1993) . Several studies have established that neurons in this ganglion express two major classes of AChRs, one recognized by monoclonal antibody (mAb) 35, known as mAb 35-AChRs, and another recognized by ␣-bungarotoxin (␣-BuTx), known as ␣-BuTx-AChRs (Vernallis et al., 1993; Conroy and Berg, 1995; Pugh et al., 1995) . Within and between these classes there is additional complexity: most of the mAb 35-AChRs include the ␣3, ␣5, and ␤4 subunits, but a subset of these receptors has, in addition, the ␤2 subunit . There is also a relatively small number of receptors that are recognized by both mAb 35 and ␣-BuTx and apparently are composed of novel AChR subunits (Pugh et al., 1995) .
Chemical synaptic transmission in the ciliary ganglion is nicotinic (Martin and Pilar, 1963; Dryer, 1994) and has been attributed to mAb 35-AChRs rather than ␣-BuTx-AChRs (Smith et al., 1983; Halvorsen et al., 1991) . ␣-BuTx does not abolish compound action potentials recorded from the postganglionic nerve in response to preganglionic nerve stimulation (Chiappinelli and Dryer, 1984) . Moreover, ␣-BuTx-AChRs are not concentrated in the synaptic membrane but rather are extrasynaptic (Jacob and Berg, 1983; Loring et al., 1985) or, more precisely, perisynaptic (Wilson Horch and Sargent, 1995) . mAb 35-AChRs, on the other hand, are concentrated at synaptic membranes (Jacob et al., 1984; Loring and Zigmond, 1987; Wilson Horch and Sargent, 1995) .
We examined whole-cell currents recorded from ciliary ganglion neurons of embryonic day 13-16 chicks and found both kinetic and pharmacological evidence that synaptic transmission is mediated in part by ␣-BuTx-AChRs. Similar results have been reported recently by Zhang et al. (1996) . We have extended these findings by (1) analyzing synaptic currents separately in both ciliary and choroid neurons, which differ in the sensitivity of their EPSCs to ␣-BuTx, and (2) dissecting the currents into those sensitive to ␣-BuTx and those sensitive to the cone snail peptide ␣-conotoxin M II (␣-C T x-M II). ␣-CTx-MII is specific for expressed mammalian AChRs containing an ␣3/␤2 subunit interface; in the ciliary ganglion ␣-CTx-MII may block currents that arise from mAb 35-AChRs.
MATERIALS AND METHODS
Chick embryos (Gallus domesticus) were obtained from Feather Hill Farms (Petaluma, CA). Embryonic day 13-16 chicks were decapitated, and ciliary ganglia were removed and pinned in a recording dish with constant flow of oxygenated glucose Ringer's solution. The sheath covering the ganglion was softened with collagenase (4 mg /ml, type A; Boehringer Mannheim, Indianapolis, I N) applied with pressure through a 15-30 m inner diameter pipette and was removed either with fine forceps or with gentle suction through the pipette (Yawo and Momiyama, 1992) . To ensure that the enzyme treatment did not damage the presynaptic innervation, some ganglia were perf used with oxygenated glucose Ringer's solution for 1 hr with no enzyme treatment and then desheathed with fine forceps. There were no statistically significant differences in EPSC amplitude or kinetics for ciliary neurons examined from enzymetreated and untreated ganglia. Neurons were viewed with a Z eiss 40ϫ water immersion objective (numerical aperture 0.75). The ganglion was perf used with glucose Ringer's solution containing (in mM): NaC l 150, KCl 3, CaCl 2 2.5 (or 5), MgC l 2 4.5 (or 2), glucose 17, and H EPES 10, pH 7.4. There was no statistically significant difference in EPSC amplitude or kinetics in 2.5 and 5.0 mM CaCl 2 . The pipette solution contained (in mM): C sC l 140, Mg-ATP 2, GTP 0.2, EGTA 2, glucose 5, and H EPES 10, pH 7.2. ␣-BuT x (50 -60 nM) was obtained from Biotoxins (St. C loud, FL). ␣-C T x-M II was synthesized as described previously (C artier et al., 1996) and stored either lyophilized or in solution at 4°C.
Whole-cell recording pipettes were pulled from borosilicate glass (W PI, Sarasota, FL) and had resistances of 1-5 M⍀. Electrodes were coated with Sigmacote (Sigma, St. L ouis, MO). The oculomotor nerve was stimulated with a suction pipette (0.5-1.0 msec, 5-10 V) at 30 -60 sec intervals. Synaptic currents were recorded from cells clamped at Ϫ60 mV with an Axopatch-1D amplifier (Axon Instruments, Foster C ity, CA), filtered at 2 kHz (Ϫ3 dB, 8-pole Bessel filter), digitized at 25 kHz (TL -1 DM A interface, Axon Instruments), and collected on computer hard drive with C lampex (pC lamp 6.0, Axon Instruments) while input resistance was continuously monitored. The measured series resistance (access resistance) was 3-5 M⍀ for ciliary neurons and 3-7 M⍀ for choroid neurons. Holding currents necessary to maintain a potential of Ϫ60 mV were from Ϫ0.01 nA to Ϫ0.09 nA. A series compensation of 80% was typically used. The measured membrane capacitance was 26 Ϯ 4 pF for ciliary neurons and 19 Ϯ 4 pF for choroid neurons, yielding a calculated time constant with compensation for the clamp circuit of ϳ25 sec. Current records that showed an inflection during the rising phase of the EPSC were not analyzed f urther because of the possibility that they were accompanied by voltage escape.
E xperiments were performed at 20 -25°C. Toxins were added to the bath through perf usion or by pipette. Responses were analyzed with C lampfit and pSTAT (pC lamp 6.0, Axon Instruments) and Origin 4.0 (Microcal, Northhampton, M A) using log maximum-likelihood estimates. Inward currents are shown as downward deflections but are given positive values in the text. Curves were fitted from 90% of peak to 10% of baseline. Samples were compared using the Mann -Whitney test or, if samples satisfied the normality and equal variance tests, the Student's t test. All values are given as the mean Ϯ SD.
RESULTS

Neuronal types in the ciliary ganglion
We distinguished ciliary neurons from choroid neurons by three criteria: cell location, cell body diameter, and number of preganglionic inputs (Dryer and Chiappinelli, 1987) . Choroid neurons are smaller than ciliary neurons and are located within one quadrant of the ganglion (Pilar et al., 1980; Dryer and Chiappinelli, 1987) . We recorded from choroid neurons by pinning the ganglion so that this quadrant was accessible and by choosing among the smallest neurons (cell body diameter Ͻ20 m) for recording. We recorded from ciliary neurons by pinning the ganglion so that the quadrant containing choroid neurons faced the bottom of the recording chamber and by recording from larger-diameter neurons (cell body diameter Ͼ20 m). We confirmed the validity of this selection procedure by noting the number of independently elicitable synaptic inputs per neuron. Choroid neurons had a minimum of three synaptic inputs, as judged by the number of abrupt increments in EPSC size evoked when the stimulus intensity was progressively increased (n ϭ 15); in contrast, ciliary neurons each had a single synaptic input (n ϭ 44) (Fig. 1) . Another difference between choroid and ciliary neurons is the size of the EPSC produced by maximal preganglionic stimulation. Ciliary neurons, which in the embryo have a single large, calyceal synapse, had large peak EPSC amplitudes, with a mean amplitude of 4.23 Ϯ 1.81 nA (range, 1.50 -8.01 nA). Choroid neurons, which have more conventional synapses and smaller EPSCs than ciliary neurons (Dryer and Chiappinelli, 1987) , had a mean peak EPSC amplitude of 0.75 Ϯ 0.34 nA in response to maximal stimulation of the preganglionic nerve (range, 0.20 -1.47 nA). Thus, the number of inputs and the peak EPSC amplitude identify ciliary and choroid neurons as unique Figure 1 . Ciliary and choroid neurons can be distinguished by the extent of synaptic convergence. The two panels show multiple, superimposed records of evoked synaptic currents recorded from a ciliary and a choroid neuron. Inward current is represented by a downward deflection. Preganglionic axons within the oculomotor nerve were gradually recruited by increasing the stimulus intensity delivered to the nerve via a suction electrode. In the left panel, a stimulus intensity of 1-3 V caused no synaptic current, whereas a stimulus of Ͼ3 V caused a large synaptic current that fluctuated little from trial to trial. When the same paradigm was applied to a choroid neuron, the EPSC increased in several increments, each with a well-defined threshold. The choroid neuron record shows two responses at each of four stimuli, one of which elicited no response. This neuron had a minimum of three independently elicitable inputs.
cell populations within the ganglion and support the validity of our identification criteria.
Kinetic analysis of EPSCs from ciliary neurons
Most of the ciliary neurons we encountered (28 of 44) had EPSCs the falling phases of which were not well fit with a single exponential f unction. An example of an EPSC from such a neuron is illustrated in Figure 2 A. A semilog plot of this EPSC (Fig. 2 B) shows that the current decays exponentially with two distinct rates. In this instance, the digitized EPSC extending from 90% of peak to 10% of baseline was significantly better fit by the sum of two exponentials than by a single exponential or by three or more exponentials. The average time constants for the rapidly and slowly decaying components of the EPSC were 1.04 Ϯ 0.35 and 11.3 Ϯ 3.3 msec, respectively. The average fraction of the EPSC amplitude, at 90% of peak, that was accounted for by the rapidly decaying phase was 41% (range, 20 -71%). The contribution of the rapidly decaying phase is somewhat greater when the fitted curves are extrapolated back to the time when the EPSC is at its peak, and it is assumed, for the sake of the calculation, that all channels open at that time. One explanation for the biexponential decay of the EPSC in these ciliary neurons is that the synaptic current is generated by the activity of two populations of channels with different burst duration. Additional evidence for this interpretation will be provided below, where we describe pharmacological isolation of each phase of the EPSC.
Not all ciliary neurons had EPSC s that decayed biexponentially. Figure 2C ,D shows an example of a record the falling phase of which is best fit by a single exponential with a time constant of 7.81 msec. The average time constant of decay of the monoexponential EPSCs was 8.25 Ϯ 2.03 msec, a number similar to the slow component of the biexponentially decaying EPSC (11.3 msec). Ciliary neurons with a single component of EPSC decay are not likely to be damaged as compared with neurons with a twocomponent EPSC; we found no difference between these two populations of recordings with regard to seal resistance, input resistance, or the amount of current needed to hold the membrane potential at Ϫ60 mV (data not shown). Are these neurons qualitatively different from those with biexponentially decaying EPSCs, or do they simply represent a subset of cells with a rapidly decaying EPSC component that is too small to detect? To assess how much rapidly decaying current must be present for detection, we generated a family of biexponential curves with time constants of 1.1 and 11.0 msec and with a variable amount of fast component (measured at 90% of the peak), and then we determined how much of the fast component must be present before it is detected by the pSTAT program. The program detected a rapidly decaying component only if Ͼ13% of the peak current was "fast." Interestingly, this is also approximately the amount of fast component needed for the eye to readily detect a biexponential trace. Thus, it is possible that a small rapidly decaying component of synaptic current may be present in ciliary neurons that appear to have monoexponentially decaying EPSCs.
To learn whether monoexponential and biexponential EPSCs represent two extremes of a continuous population, we subjected all EPSC decays to the curve-fitting procedure assuming two components, and we then plotted the fraction of the total current attributable to the rapidly decaying component as a cumulative frequency distribution. For 13 of the 16 apparently monoexpo- nentially decaying EPSC s, the pCL AM P curve-fitting program produced a trivial second component of EPSC decay (e.g., with an amplitude of 10 Ϫ5 nA), and we assumed that there was no rapidly decaying component in these recordings. For the three remaining apparently monoexponential recordings, the pCL AM P program assigned a small component of rapidly decaying current, amounting to 3-5% of the total. A cumulative frequency distribution for the fraction of EPSC that is fast for all 44 ciliary neurons (Fig. 3) shows a discontinuity: 36% of the neurons (16/44) have EPSC s with Ͻ5% of the current decaying rapidly, whereas 64% of the neurons (28/44) have EPSC s with Ͼ20% of the current decaying rapidly, but no neurons have EPSCs with intermediate values (5-20%) . This suggests that the two populations of neurons characterized as biexponential or monoexponential are distinct. Another finding that supports this interpretation is that the time constants for EPSC decay for the slow component of "biexponential" neurons and for the only component of "monoexponential" neurons are significantly different (Fig. 4) (means of 11.3 Ϯ 3.3 and 8.25 Ϯ 2.03 msec, respectively; p ϭ 0.016 by Student's t test, which in this instance had a power of 0.62, below the desired power of 0.80). Could the difference in time constant have arisen artifactually as the result of a systematic error in the curve-fitting procedure? Probably not: the algorithm is able to estimate to within 1% accuracy the time constant for the slowly decaying phase when asked to analyze families of theoretical curves in which a slow phase is mixed with varying amounts of a fast phase (not shown). The amplitude of the two components was similar (3.01 Ϯ 1.32 and 2.92 Ϯ 0.84 nA at 90% of peak; p ϭ 0.88 by Mann -Whitney rank sum test). Thus, monoexponential ciliary neurons appear to be qualitatively different from neurons the EPSC s of which decay with two exponentials by two criteria: (1) differences in the fraction of the EPSC that is rapidly decaying and (2) differences in the time constant of decay for the slow phase. The difference in the time constants for these two populations implies that the burst duration for the underlying channels is different.
Ciliary neurons having little or no rapidly decaying EPSC component (i.e., "monoexponentials") accounted for 36% of neurons in the sample we encountered; however, this may not reflect the actual fraction of these neurons within the ganglion, because we recorded only from neurons at selected parts of the periphery of the ganglion. Our results are consistent with there being comparable numbers of the two types of neurons in the ganglion.
Pharmacology of ciliary EPSCs
We isolated each component of ciliary EPSCs pharmacologically with the use of the neurotoxins ␣-BuTx and ␣-CTx-MII. Within the ciliary ganglion, 95% of AChRs recognized by ␣-BuTx contain ␣7 subunits (Pugh et al., 1995) , whereas ␣-CTx-MII is specific, among heterologously expressed mammalian AChRs, for ␣3␤2 AChRs (Cartier et al., 1996) . As illustrated in Figure 5A , 50 nM ␣-BuTx reduced the peak amplitude of the EPSC and had less effect on the slowly decaying phase of the current (Fig. 5A , semilog trace). In all three instances when ␣-BuTx was added to the bath while we recorded from a "biexponential" ciliary neuron, the EPSC was reduced to a single component of decay with a time course indistinguishable from that of the slow component present before addition of the toxin ( ϭ 13.7 Ϯ 4.1 msec before and 11.8 Ϯ 5.3 msec after toxin; p ϭ 0.65 by paired Student's t test). The amplitude of the slowly decaying component was reduced by ϳ50% from that present before the addition of toxin (amplitude at 90% of peak ϭ 2.62 Ϯ 0.88 nA before and 1.30 Ϯ 0.55 nA after; p ϭ 0.005 by paired t test). In control experiments in which we maintained whole-cell recordings for 45 min, the longest duration of a toxin experiment, we saw only a modest loss in amplitude of the EPSC or of either of its components (3-10%; n ϭ 4).
In four experiments in which we recorded from neurons in 200 nM rather than 50 nM ␣-BuTx, we found no statistically significant difference between the amplitude or time course of EPSCs recorded at these two concentrations ( p ϭ 0.34; Student's t test). The cumulative distribution of the relative amount of rapidly decaying current in ciliary EPSC s suggests two distinct ciliary neuron populations. All ciliary neuron EPSC s were fitted assuming two phases of decay, and the ratio of the amplitude of the fast component to the total current (at 90% of peak) is displayed in a cumulative distribution plot. The plot shows a break in the distribution of amplitude ratios, with one group showing 20% or more of the fast component and another group showing 5% or less of the fast component.
Therefore, 50 nM ␣-BuTx has a maximal effect on both the fast and slow time course of the synaptic current.
The effects of ␣-BuTx on ciliary neuron EPSCs were not readily reversible. In two experiments we were able to hold neurons for at least 30 min after toxin washout, and in each instance there was no measurable return of the rapidly decaying response nor was there an increase in the size of the slowly decaying response. ␣-BuTx begins to have an effect within 5 min of its addition to the bath, and so the failure to see a recovery is presumably attributable to the fact that the toxin remains bound to its receptor.
␣-CTx-MII had an effect on biexponentially decaying ciliary neuron EPSCs that was complementary to that of ␣-BuTx. Figure  5B shows an example of the effects of 50 nM ␣-CTx-MII on a biexponentially decaying EPSC of a ciliary neuron. The toxin altered the trace to a monoexponentially decaying one, with a time constant of decay similar to that of the rapidly decaying component present beforehand; similar results were found in each of four other experiments. A comparison of the properties of the rapidly decaying phase before and after ␣-CTx-MII suggests that its amplitude is unchanged (90% of peak ϭ 1.88 Ϯ 1.01 and 2.15 Ϯ 1.00 nA, respectively; p ϭ 0.18 by paired t test) but that its time constant is increased (from 1.16 Ϯ 0.35 to 1.88 Ϯ 0.34 msec; p ϭ 0.019 by paired t test). We believe, however, that this increase is only apparent and is the result of inaccuracies in the curvefitting procedure. Thus, when we construct artificial biexponentially decaying curves with 90% or more fast current ( ϭ1.2 msec) and 10% or less slow current ( ϭ12.0 msec), the Clampfit curve-fitting algorithm, which examines the curve from 90% of peak to 10% of baseline, sometimes overestimates the time constant for the rapidly decaying component by up to 75% ( yielding, for example, 1.8 msec for a component that actually decays at 1.2 msec). This can be understood by assuming that the program is unable to separate completely the two phases of decay and has "contaminated" the rapid phase with the slower phase. This was a problem only with curves with large amounts of rapidly decaying current and small amounts of slowly decaying current, and not vice versa.
The use of higher concentrations of ␣-CTx-MII (200 nM) did not reduce the amplitude of the rapidly decaying component (data not shown). There was also no difference in the time course of EPSC s recorded in 50 nM versus 200 nM ␣-CTx-MII ( p ϭ 0.7 by Student's t test). This implies that ␣-CTx-MII, like ␣-BuTx, has a maximal effect by 50 nM.
Application of 50 nM ␣-CTx-MII followed by 50 nM ␣-BuTx blocked the ciliary neuron EPSC nearly completely (Fig. 6 ) (similar results were seen in two other experiments). This demonstrates that nicotinic AChRs sensitive to either ␣-BuTx or ␣-CTx-MII account for nearly all the synaptic current elicited from some ciliary neurons by nerve-released transmitter. In one ganglion we detected very small (0.06 nA) currents in two of five neurons examined in the presence of both 200 nM ␣-BuTx and 200 nM ␣-CTx-MII (data not shown). This represents 1.4% of the peak current of the average ciliary EPSC. It is possible that some neurons contain a small-amplitude current insensitive to both toxins, but we cannot rule out trivial explanations, such as incomplete access of the toxins to all synaptic sites.
The effect of ␣-BuTx and ␣-CTx-MII on biexponentially decaying ciliary neuron EPSCs suggests that ␣-BuTx blocks the rapidly decaying component and a fraction of the slowly decaying component of current, whereas ␣-CTx-MII blocks the slowly decaying component of the current. In a few experiments we tested the effects of these toxins on monoexponentially decaying ciliary EPSCs and found that this current behaved pharmacologically like the slowly decaying component of biexponential EPSCs. Figure 7A shows an example: ␣-BuTx reduced the peak by ϳ50% but did not affect the time constant of decay. In three experiments we found a significant reduction in the amplitude of the response (2.43 Ϯ 1.03 vs 1.27 Ϯ 0.71 nA; p ϭ 0.044 by paired t test) without a significant effect on the time constant of decay (6.73 Ϯ 0.84 vs 7.93 Ϯ 2.67 msec; p ϭ 0.4 by paired t test). This argues that the slowly decaying components of the EPSC in "biexponential" and "monoexponential" ciliary neurons are pharmacologically similar, despite that fact that the time constants of their decay are different.
␣-CTx-MII had an effect on monoexponentially decaying ciliary EPSCs quite different from that of ␣-BuTx. Figure 7B shows an example in which 50 nM ␣-CTx-MII reduced the amplitude of the EPSC drastically; the surviving current had a decay considerably more rapid than that recorded beforehand. In six experi- ments we found a pronounced effect on the amplitude of the monoexponentially decaying ciliary EPSC s (from 3.30 Ϯ 1.60 to 0.62 Ϯ 0.19 nA; p ϭ 0.03 by paired t test) and a significant change in the time constant of decay (from 9.4 Ϯ 1.6 to 1.5 Ϯ 0.5 msec; p ϭ 0.0002 by paired t test). These results are consistent with the suggestion that ciliary EPSC s that appear to decay monoexponentially do indeed have a minor component of rapidly decaying current that is too small to detect by curve-fitting procedures but that can be unveiled with ␣-CTx-MII. ␣-BuTx may reduce the amplitude of these currents by eliminating the rapidly decaying component as well as some of the slowly decaying component.
Choroid neuron EPSC kinetics and pharmacology
Choroid neurons are distinct from ciliary neurons by having multiple inputs-as many as six. Because some of these inputs are small and produced EPSC s that fluctuated from trial to trial, we analyzed the kinetics and pharmacology of choroid neuron EPSC s by eliciting release from all preganglionic inputs simultaneously via maximal stimulation of the preganglionic nerve.
The decaying phase of choroid EPSC s was best described by a single exponential function in all instances (n ϭ 15) (Fig. 8) . The time constant describing the decay of choroid neuron EPSCs, 11.8 Ϯ 2.0 msec, was similar to that for the slow phase of EPSC decay for biexponential ciliary neurons ( p ϭ 0.81 by Student's t test) but was significantly different from the corresponding value for monoexponentially decaying ciliary neuron EPSCs ( p ϭ 0.005 by Student's t test).
The pharmacological sensitivity of choroid neurons to ␣-BuTx and ␣-CTx-MII was similar to that of monoexponential ciliary EPSC s. Figure 9A shows an example of the effects of 50 nM ␣-BuTx on a choroid neuron EPSC. The peak response is reduced somewhat, with little effect on the decay phase of the current. In three experiments, 50 nM ␣-BuTx reduced the amplitude of the EPSC (from 0.92 Ϯ 0.38 to 0.34 Ϯ 0.16 nA; p ϭ 0.047 by paired t test) but had no significant effect on the time constant of EPSC decay (12.8 Ϯ 3.5 to 14.4 Ϯ 2.3 nA; p ϭ 0.12 by paired t test). By contrast, ␣-CTx-MII had a profound effect on choroid neuron EPSC s. Figure 9B shows an example in which 50 nM ␣-CTx-MII reduced the peak amplitude by well over 50%; in four experiments 50 nM ␣-CTx-MII reduced the peak response by 84% (0.98 Ϯ 0.56 to 0.12 Ϯ 0.09 nA; p ϭ 0.04 by t test). The small component of ␣-CTx-MII-resistant current decayed rapidly but was too small to permit us to measure its time constant accurately. The effects of ␣-BuTx and ␣-CTx-MII on choroid neuron EPSCs can be understood by assuming that like monoexponential ciliary EPSC s, choroid EPSC s contain a major component of slowly decaying current completely sensitive to ␣-CTx-MII and partially sensitive to ␣-BuTx and a minor component of rapidly decaying current sensitive to ␣-BuTx.
DISCUSSION
We have analyzed the kinetics and pharmacology of EPSCs from ciliary ganglion neurons. Most of the ciliary neurons that we sampled had EPSCs that decayed biexponentially, with time constants of ϳ1 and 10 msec. The rapidly decaying component of the EPSC was completely blocked by ␣-BuTx, whereas the slowly decaying component was partially blocked by ␣-BuTx and completely blocked by ␣-CTx-MII. The remainder of the ciliary neurons, and all sampled choroid neurons, had EPSCs that appeared to be monoexponential, having a time constant of ϳ10 msec; however, pharmacological evidence suggests that these neurons also had rapidly and slowly decaying components, with sensitivity to ␣-BuTx and ␣-CTx-MII similar to that of their biexponential counterparts. These findings complement the recent results of Zhang et al. (1996) , who reported on the dual nature of EPSC decay of an unselected population of ciliary ganglion neurons and on the sensitivity of the rapidly decaying component of EPSC to ␣-BuTx.
The two components of EPSC decay probably represent the behavior of different populations of AChR channels. If transmitter is present briefly in the synaptic cleft, such that no channels open for the first time during the falling phase of the EPSC, then the principal determinant of EPSC falling phase should be the channel burst duration. This implies that nerve-released ACh has access to at least two populations of receptor-channel complexes, and this interpretation is borne out by the pharmacological data.
Four populations of ACh channels have been detected on neurons cultured from embryonic day 14 ciliary ganglion, with conductances of 25, 40, 60, and 80 pS (Margiotta and Gurantz, 1989; J. Margiotta, personal communication) . The open lifetime histograms for the 25 and 40 pS channels were dominated by events having mean open times of ϳ1 msec, whereas the 60 and 80 pS events were briefer (0.1-0.3 msec). The 60 and 80 pS events are abolished by ␣-BuTx (J. Margiotta, personal communication) , suggesting that they may underlie the rapidly decaying component of the EPSC, whereas the 25 and 40 pS events may underlie the slowly decaying component of the EPSC. The difference between the mean open times and the EPSC decay time constants may reflect differences in the lifetimes of individual channel openings versus bursts of openings contributing to the falling phase of the EPSC.
The fast component of current decay is likely caused by ␣7 AChR, because of both its rapid time course and its sensitivity to ␣-BuTx (Couturier et al., 1990; Anand et al., 1993 ; Zhang et al., 1994; Pugh et al., 1995) . ␣7-containing AChRs are abundant in the ciliary ganglion , and all ganglion neurons express ␣-BuTx receptors (Jacob and Berg, 1983; Wilson Horch and Sargent, 1995) . If the 20 fmol of ␣-BuTx AChRs in the ganglion were distributed evenly and exclusively among its 3000 neurons, then each neuron would have ϳ4 ϫ 10 6 receptors. If we take 70 pS as an open channel conductance for these receptors (see above), then the single channel current would be ϳ4 pA with a driving force of Ϫ60 mV. Only a few thousand such receptors, if activated synchronously, would be needed to produce the ␣-BuTx-sensitive component observed.
␣-BuTx at 50 nM blocked most of the rapidly decaying EPSC and about half of the slowly decaying EPSC from biexponential ciliary neurons. Incomplete block of the slowly decaying current is not likely to have resulted from a partial occupancy of a lowaffinity AChR, because the block was not enhanced at 200 nM ␣-BuTx. These data are consistent with the existence of two populations of ␣-BuTx-sensitive AChRs, one of which is also sensitive to ␣-CTx-MII. No known AChR subunit combination is sensitive to both ␣-BuTx and ␣-CTx-MII, including ␣7 homooligomers and ␣x␤y hetero-oligomers in which x ϭ 2, 3, or 4, and y ϭ 2 or 4 (Johnson et al., 1995; C artier et al., 1996) . Perhaps ␣7-containing AChRs in the ganglion include both homooligomers, which presumably underlie the rapidly decaying EPSC component, and hetero-oligomers (Listerud et al., 1991) ; however, immunochemical studies (Vernallis et al., 1993; Conroy and Berg, 1995) have not found a detectable association between ␣7 subunits and other identified AChR subunits in the ganglion (␣3, ␣5, ␤2, or ␤4). Another possibility is that the AChRs that underlie the ␣-BuTx-sensitive, slowly decaying EPSC are those recently identified by Pugh et al. (1995) that are recognized by ␣-BuTx but have neither ␣7 nor any of the other AChR subunit gene products identified in the ganglion.
␣-CTx-MII is selective for ␣3␤2 AChRs among mammalian types expressed in oocytes (Cartier et al., 1996) and may be blocking an AChR containing these subunits in the ciliary ganglion, given the high degree of homology between rat and chicken sequences (70 -90% at the amino acid level). The ␣3 and ␤2 subunits are both present in the ciliary ganglion (Vernallis et al., 1993; Conroy and Berg, 1995) , and immunoreactivity corresponding to both subunits is expressed in all neurons within the ganglion (H. L. Wilson Horch and P. B. Sargent, unpublished observations). Vernallis et al. (1993) and Conroy and Berg (1995) have found that all AChRs in extracts of the ganglion that contain immunoreactivity corresponding to the ␣3 and the ␤2 subunits also contain the ␣5 and ␤4 subunits. This suggests that the target for ␣-CTx-MII may be an AChR oligomer with four different subunits.
Our pharmacological results on biexponential ciliary neurons are generally similar to those of Zhang et al. (1996) . One difference is that we find that 50 nM ␣-BuTx has a more modest effect on peak EPSCs: the average reduction in the peak of the biexponential EPSC was 71% in our experiments and 92% in theirs. A second difference, which might be explained by differences in sampling, is that we found both neurons with biexponential EPSC decays and those with monoexponential decays, whereas Zhang et al. (1996) reported finding only neurons with biexponential 
